Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanlan Ji

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|May 5, 2023
Presence of tophi and carotid plaque were risk factors of MACE in subclinical artherosclerosis patients with gout: a longitudinal cohort studyYu Wang, Xuerong Deng, Xiaohui Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2023
CellCover Captures Neural Stem Cell Progression in Mammalian Neocortical DevelopmentLanlan Ji, An Wang, Shreyash Sonthalia, et al.
Rheumatology (Oxford, England)|October 18, 2019
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancyWenhui Xie, Shiyu Xiao, Yanrong Huang, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2026
A cunning impersonator of autoimmune diseasesChunyu Xu, Dai Gao, Xiaoying Sun, et al.
Rheumatology (Oxford, England)|April 12, 2022
Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goalLanlan Ji, Dai Gao, Yanjie Hao, et al.
Rheumatology and Therapy|July 7, 2023
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World StudyXiaohui Zhang, Hong Huang, Dai Gao, et al.
Seminars in Arthritis and Rheumatism|June 9, 2020
Intensive therapy alleviates subclinical synovitis on ultrasound and disease activity and reduces flare in rheumatoid arthritis patients who have achieved clinical target - a randomized controlled trialJuan Zhao, Yu Wang, Yan Geng, et al.
Lupus Science & Medicine|March 4, 2022
Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort studyYanjie Hao, Lanlan Ji, Dai Gao, et al.
Rheumatology (Oxford, England)|December 23, 2020
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancyWenhui Xie, Shiyu Xiao, Yanrong Huang, et al.
Mayo Clinic Proceedings|April 3, 2026
Redefining Initial Rheumatoid Arthritis Treatment: Tofacitinib Outperforms Methotrexate in Disease Control - An Open-Label Randomised Controlled TrialJuan Zhao, Yu Wang, Xuerong Deng, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|May 5, 2023
Presence of tophi and carotid plaque were risk factors of MACE in subclinical artherosclerosis patients with gout: a longitudinal cohort studyYu Wang, Xuerong Deng, Xiaohui Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2023
CellCover Captures Neural Stem Cell Progression in Mammalian Neocortical DevelopmentLanlan Ji, An Wang, Shreyash Sonthalia, et al.
Rheumatology (Oxford, England)|October 18, 2019
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancyWenhui Xie, Shiyu Xiao, Yanrong Huang, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2026
A cunning impersonator of autoimmune diseasesChunyu Xu, Dai Gao, Xiaoying Sun, et al.
Rheumatology (Oxford, England)|April 12, 2022
Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goalLanlan Ji, Dai Gao, Yanjie Hao, et al.
Rheumatology and Therapy|July 7, 2023
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World StudyXiaohui Zhang, Hong Huang, Dai Gao, et al.
Seminars in Arthritis and Rheumatism|June 9, 2020
Intensive therapy alleviates subclinical synovitis on ultrasound and disease activity and reduces flare in rheumatoid arthritis patients who have achieved clinical target - a randomized controlled trialJuan Zhao, Yu Wang, Yan Geng, et al.
Lupus Science & Medicine|March 4, 2022
Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort studyYanjie Hao, Lanlan Ji, Dai Gao, et al.
Rheumatology (Oxford, England)|December 23, 2020
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancyWenhui Xie, Shiyu Xiao, Yanrong Huang, et al.
Mayo Clinic Proceedings|April 3, 2026
Redefining Initial Rheumatoid Arthritis Treatment: Tofacitinib Outperforms Methotrexate in Disease Control - An Open-Label Randomised Controlled TrialJuan Zhao, Yu Wang, Xuerong Deng, et al.
Pageof 7